SHS-010(Nanjing Sanhome Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSHS-010(Nanjing Sanhome Pharmaceutical)
Drug Alias NameSHS-010
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-CTLA4Anti-PD-1
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Sanhome Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Sanhome Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A